Fabio Del Bello Selected Research

Xerostomia

8/2014

Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Del Bello Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 11/2014
5	Pain (Aches) 01/2023 - 11/2009
3	Bulimia (Binge Eating) 01/2023 - 01/2019
3	Feeding and Eating Disorders (Eating Disorder) 01/2023 - 07/2020
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 07/2020
2	Obesity 01/2023 - 10/2021
2	Neuralgia (Stump Neuralgia) 01/2020 - 09/2017
2	Prostatic Neoplasms (Prostate Cancer) 04/2019 - 12/2014
2	Breast Neoplasms (Breast Cancer) 04/2019 - 02/2010
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2019
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 08/2015 - 07/2012
2	Morphine Dependence 07/2012 - 11/2010
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Body Weight (Weight, Body) 10/2021
1	Bone Resorption 01/2021
1	Communicable Diseases (Infectious Diseases) 12/2020
1	Chronic Pain 08/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Dyskinesias (Dyskinesia) 01/2019
1	Chronic Disease (Chronic Diseases) 12/2015
1	Xerostomia 08/2014
1	Opioid-Related Disorders (Opiate Addiction) 09/2013
1	Depressive Disorder (Melancholia) 09/2013
1	Salter-Harris Fractures 02/2013

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 01/2023 - 09/2017
5	5-HT1A Serotonin ReceptorIBA 04/2019 - 07/2012
5	Morphine (MS Contin)FDA LinkGeneric 12/2015 - 11/2009
3	ImidazolinesIBA 01/2020 - 12/2015
3	1,4-dioxane (dioxane)IBA 04/2019 - 01/2019
2	EnzymesIBA 01/2023 - 10/2021
2	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 04/2020
2	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 01/2022 - 07/2020
2	CateninsIBA 01/2021 - 02/2013
2	N-Methylaspartate (NMDA)IBA 04/2020 - 04/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2020 - 04/2019
2	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2017 - 08/2015
2	Opioid Analgesics (Opioids)IBA 12/2015 - 01/2012
2	2- (1- (2- allylphenoxy)ethyl)- 4,5- dihydro- 1H- imidazoleIBA 08/2015 - 07/2012
2	Antidepressive Agents (Antidepressants)IBA 08/2015 - 07/2012
1	NAD (NADH)IBA 01/2023
1	Coenzymes (Enzyme Cofactors)IBA 01/2023
1	neuromedin UIBA 01/2023
1	Dopamine D3 ReceptorsIBA 10/2021
1	GhrelinIBA 10/2021
1	Hormones (Hormone)IBA 10/2021
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	AcyltransferasesIBA 10/2021
1	MetalsIBA 12/2020
1	Trace Elements (Biometals)IBA 12/2020
1	ZincIBA 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Formaldehyde (Formol)FDA Link 08/2019
1	Antineoplastic Agents (Antineoplastics)IBA 04/2019
1	spipethianeIBA 01/2019
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Yohimbine (Yocon)IBA 09/2017
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 09/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2017
1	Hypnotics and Sedatives (Sedatives)IBA 08/2015
1	Ion Channels (Ion Channel)IBA 12/2014
1	CalciumIBA 12/2014
1	Phosphotransferases (Kinase)IBA 11/2014
1	NucleosidesIBA 11/2014
1	cevimeline (Evoxac)FDA Link 08/2014
1	Opiate AlkaloidsIBA 09/2013
1	Naloxone (Narcan)FDA LinkGeneric 07/2012
1	Cytostatic AgentsIBA 02/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2009

Therapy/Procedure

4	Analgesia 08/2015 - 11/2009
2	Therapeutics 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Oral Administration 01/2020